Acute effects of alcohol on evoked potentials in visual cortex and superior colliculus of the rat

Electroencephalography and Clinical Neurophysiology
B E HetzlerG Griffin

Abstract

This study examined the effects of alcohol on visually evoked potentials recorded from the primary visual cortex (VC) and superior colliculus (SC) of chronically implanted rats. Animals were given intraperitoneal injections of saline, and of 0.15, 0.5, 1.0 and 1.5 g ethanol/kg body weight on separate days. Evoked potentials were recorded at 5, 20, 40, and 60 min following injection. There were differential effects of both alcohol and habituation on the early versus late VC components. The amplitudes of the late components decreased over time and were also depressed by both the 1.0 and 1.5g/kg doses of alcohol. Amplitudes of the early components increased over time and were unaffected by the 1.0g/kg alcohol dose. The 1.5g/kg dose depressed the early negative component but augmented the early positive component. In contrast to the amplitudes, the latencies of both early components were increased at both the l.0 and 1.5g/kg doses. However, the latency of the late positive component was increased at only the 1.5 g/kg dose, while the latency of the late negative component was unaffected by any alcohol dose. In the SC, the peak amplitude of the early positive complex was unaffected by either habituation or alcohol. However, both the ...Continue Reading

References

Jun 1, 1975·Electroencephalography and Clinical Neurophysiology·L E RhodesD Creel
Nov 1, 1978·Electroencephalography and Clinical Neurophysiology·K C SquiresA Starr
Dec 1, 1979·Electroencephalography and Clinical Neurophysiology·A PfefferbaumB S Kopell
Mar 15, 1979·Documenta Ophthalmologica. Advances in Ophthalmology·G H van Lith, H E Henkes
Jan 1, 1977·Advances in Experimental Medicine and Biology·H Begleiter, B Porjesz
Nov 1, 1977·Journal of Studies on Alcohol·F W ObitzD Creel
Nov 15, 1978·Experimental Brain Research·L H MathersP E Marshall
Apr 1, 1977·Pharmacology, Biochemistry, and Behavior·R S Dyer, Z Annau
Jan 1, 1975·Journal of Comparative and Physiological Psychology·J S Schwartzbaum, C J Kreinick
Jan 1, 1975·Advances in Experimental Medicine and Biology·B Porjesz, H Begleiter
Nov 1, 1970·Electroencephalography and Clinical Neurophysiology·L E Rhodes, D E Fleming
Jan 1, 1974·Electroencephalography and Clinical Neurophysiology·R G PerrinK E Livingston
Feb 1, 1968·Electroencephalography and Clinical Neurophysiology·R D Hall
Feb 1, 1970·Electroencephalography and Clinical Neurophysiology·E G LewisE C Beck
Mar 1, 1973·European Journal of Pharmacology·Y NakaiS Takaori
Jul 1, 1973·Acta Physiologica Scandinavica·C G BernhardH E Persson
Feb 1, 1972·Behavioral Biology·H BegleiterB Kissin
Nov 1, 1970·Experimental Neurology·D J CreelE C Beck
Jul 8, 1966·Science·D S Ruchkin, E R John
Aug 1, 1959·Journal of Comparative and Physiological Psychology·J A CARPENTER
Jan 1, 1965·Experimental Neurology·J M SPRAGUE, T H MEIKLE

❮ Previous
Next ❯

Citations

Jan 6, 1999·The Journal of Pathology·J L ShannonA J Howie
Jun 1, 1982·Electroencephalography and Clinical Neurophysiology·J M FusterJ W Ashford
Feb 1, 1982·Physiology & Behavior·M OnofrjP Bobak
Dec 1, 1982·Pharmacology, Biochemistry, and Behavior·B E HetzlerT Vestal
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·B E HetzlerK E Oaklay
Jan 1, 1993·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·W K BoyesR S Dyer
Apr 22, 2004·Pharmacology, Biochemistry, and Behavior·Bruce E Hetzler, Maraty Theinpeng
Jan 4, 1998·Pharmacology, Biochemistry, and Behavior·B E Hetzler, H L Zeisset
Mar 18, 1999·Pharmacology, Biochemistry, and Behavior·B E Hetzler, H K Burkard
Nov 26, 2013·Pharmacology, Biochemistry, and Behavior·Bruce E HetzlerBruce A Stickle
Oct 15, 2008·The International Journal of Neuroscience·Bruce E HetzlerElizabeth A Becker
Dec 1, 2010·Pharmacology, Biochemistry, and Behavior·Bruce E Hetzler, Elizabeth J Beckman
Apr 5, 2007·Pharmacology, Biochemistry, and Behavior·Bruce E Hetzler, Janie M Ondracek
Oct 1, 1986·Alcoholism, Clinical and Experimental Research·L T RutledgeM A Sutter
Jan 25, 2006·Pharmacology, Biochemistry, and Behavior·Bruce E Hetzler, Elizabeth I Martin
Dec 12, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Bruce E Hetzler, Alison M Bauer
Feb 3, 2011·British Journal of Clinical Pharmacology·Remco W M ZoethoutJoop M A van Gerven

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.